Sermorelin (GHRH 1-29 acetate) serves as a baseline reference agonist for studying pituitary somatotroph signaling and endogenous growth hormone release dynamics. Institutional investigators requiring analytical consistency can purchase Sermorelin 15mg engineered specifically for standardized in vitro and animal model protocols.
Sermorelin (GHRH 1-29 acetate) serves as a baseline reference agonist for studying pituitary somatotroph signaling and endogenous growth hormone release dynamics. Institutional investigators requiring analytical consistency can purchase Sermorelin 15mg engineered specifically for standardized in vitro and animal model protocols.
To buy Sermorelin 15mg for laboratory research, verified institutional buyers select US-manufactured suppliers offering analytical transparency. PX1 Research supplies high-purity lyophilized Sermorelin acetate (15mg) tested via ISO 17025 RP-HPLC and mass spectrometry to ensure >98% sequence purity, low endotoxin levels, and consistent lot-to-lot stability for in vitro and preclinical somatotropic signaling studies.
When procuring compounds for high-precision assays, chemical integrity directly impacts experimental reproducibility. Substandard or unverified peptides introduce confounding variables such as truncated peptide fragments, residual TFA salts, or endotoxin contamination that can distort receptor binding data. Principal investigators should reference our full catalog of research peptides or explore our dedicated Sermorelin 15mg product page to review lot-specific analytical documentation before initiating protocols.
Sermorelin is a synthetic 29-amino-acid peptide derived from the naturally occurring human growth hormone-releasing hormone (GHRH), which comprises 44 amino acids. The truncated sequence—specifically GHRH(1-29)—represents the minimal functional sequence required to maintain full biological affinity and intrinsic activity at the GHRH receptor target.
The molecular formula of Sermorelin acetate is C149H246N44O42S with a theoretical molecular mass of approximately 3357.88 Da. The chemical structure retains the NH2-terminal residue sequence critical for binding to signal transduction domains on anterior pituitary somatotrophs. Understanding this primary structural integrity is essential when designing comparative binding assays or studying peptide-receptor interaction kinetics within the broader category of GHRH analogs.
Sermorelin functions selectively as a GHRH receptor agonist. Upon binding to the G-protein coupled GHRH receptor located on the cell membrane of anterior pituitary somatotrophs, the ligand triggers a conformational change that activates the Gαs subunit.
This activation stimulates membrane-bound adenylyl cyclase, leading to an intracellular elevation of cyclic adenosine monophosphate (cAMP). High cAMP levels activate protein kinase A (PKA), which subsequently opens voltage-gated calcium channels. In vitro data indicate that this influx of intracellular calcium induces the exocytosis of pre-stored growth hormone vesicles into the culture medium or vascular compartment in animal models. Because Sermorelin acts strictly through endogenous feedback loops, its signaling cascade remains subject to natural somatostatin-mediated inhibition.
In preclinical rodent and non-human primate models, Sermorelin has been extensively evaluated to map the physiology of pulsatile growth hormone secretion. Unlike exogenous GH administration, which overrides native regulatory axes, GHRH(1-29) preserves natural physiological pulsing patterns.
Preclinical studies suggest that Sermorelin administration stimulates episodic GH release while preserving feedback sensitivity to somatostatin (SRIF) and insulin-like growth factor 1 (IGF-1). Furthermore, investigators utilizing animal models of age-related endocrine decline have observed that Sermorelin restores youthful somatototroph responsiveness without causing receptor down-regulation or desensitization when delivered in biological pulses. Researchers analyzing broader endocrine signaling networks can examine structural interactions documented in our peptide research hub.
Within neuroendocrine research, researchers frequently evaluate Sermorelin alongside other secretagogues to differentiate terminal half-life, receptor affinity, and cascade dynamics. While Sermorelin represents the native 1-29 core peptide with a brief biological half-life (approx. 10–20 minutes in plasma assays), modified peptides exhibit vastly different pharmacokinetic profiles.
For instance, CJC-1295 incorporates tetrasubstituted amino acid modifications designed to resist enzymatic degradation by dipeptidyl peptidase IV (DPP-IV), drastically extending its circulating half-life. Similarly, Tesamorelin features a trans-3-hexenoic acid group attached to the N-terminus of the GHRH structure, optimizing its stability for specific metabolic investigations. In contrast, ghrelin receptor agonists like Ipamorelin target the growth hormone secretagogue receptor (GHSR-1a) rather than the GHRH receptor, making combination studies common when investigating synergistic secretagogue signaling pathways.
Proper reconstitution technique is imperative to maintain the tertiary structure and bioactivity of lyophilized Sermorelin 15mg. Reconstitution should always take place under a laminar flow hood using sterile laboratory technique.
To reconstitute a 15mg vial of lyophilized Sermorelin acetate:
1. Allow the vial to equilibrate to ambient room temperature (20°C–25°C) prior to fluid introduction to reduce thermal stress on the lyophilized cake.
2. Sanitize the rubber stopper using a 70% isopropyl alcohol wipe.
3. Slowly introduce an appropriate volume of Bacteriostatic Water (containing 0.9% benzyl alcohol) or Sterile Water for Injection along the internal glass wall of the vial. Avoid spraying liquid directly onto the lyophilized cake.
4. Gently swirl the vial in a circular motion until the cake dissolves completely. Do not vortex or vigorously shake the solution, as mechanical shear stress can cause peptide denaturation or aggregation.
Lyophilized Sermorelin 15mg maintains physical stability when stored under controlled temperature parameters. For long-term preservation prior to reconstitution, the lyophilized powder must be stored at -20°C in a manual defrost freezer away from light moisture exposure.
Once reconstituted into aqueous solution, the peptide is significantly more vulnerable to hydrolytic degradation and oxidation. Reconstituted Sermorelin solutions should be stored at 2°C to 8°C (refrigerated) and used within 28 days when preserved with bacteriostatic agents. Repeated freeze-thaw cycles must be strictly avoided as freeze-thaw stress leads to peptide cleavage and insoluble aggregate formation.
High-performance liquid chromatography (RP-HPLC) and mass spectrometry (MS) represent the gold standard for peptide analytical testing. PX1 Research subjects every synthesized lot of Sermorelin 15mg to rigorous analytical validation prior to release.
Reverse-Phase HPLC measures chemical purity by separating the target sequence from synthesis impurities, ensuring a minimum threshold of >98% purity. Electrospray Ionization Mass Spectrometry (ESI-MS) or MALDI-TOF confirms exact molecular weight identity, verifying the precise 3357.88 Da profile. Additionally, Limulus Amebocyte Lysate (LAL) testing is performed to quantify bacterial endotoxin levels, ensuring levels remain below strictly controlled thresholds (<0.01 EU/mg) to prevent non-specific inflammatory responses in cellular assays.
PX1 Research manufactures all research peptides in compliant US-based facilities operating under strict Quality Management Systems (QMS). Synthetic peptide synthesis utilizes advanced automated solid-phase peptide synthesis (SPPS) platforms with strict raw material traceability.
Analytical verification is conducted through independent, third-party ISO 17025 accredited laboratories. Every vial of Sermorelin 15mg shipped from our California or Arizona fulfillment hubs is assigned a unique lot number corresponding directly to a downloadable Certificate of Analysis (COA). Facilities interested in establishing recurring high-volume orders or bulk enterprise supply agreements are encouraged to apply through the PX1 Research wholesale program.
What is the physical state and format of Sermorelin 15mg supplied by PX1 Research?
Sermorelin 15mg is supplied as a sterile, lyophilized (freeze-dried) cake or powder in a sealed glass serum vial. It requires reconstitution with a suitable laboratory diluent prior to experimental use.
What is the recommended reconstitution solvent for Sermorelin 15mg?
For multi-use laboratory experiments spanning several days or weeks, Bacteriostatic Water (0.9% benzyl alcohol) is recommended to prevent microbial growth. For single-assay applications requiring absence of preservatives, sterile 0.9% sodium chloride or sterile water for injection may be utilized.
How does PX1 Research verify the purity of Sermorelin 15mg?
Every lot undergoes independent ISO 17025 analytical testing using Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC) for purity determination and Mass Spectrometry (MS) for molecular weight confirmation. Certificates of Analysis are publicly accessible for every lot.
What are the acceptable endotoxin limits for PX1 Research peptides?
PX1 Research enforces strict quality thresholds requiring endotoxin levels to test below 0.01 EU/mg via Chromogenic LAL assays, preventing artifactual cell activation or endotoxin toxicity during sensitive in vitro protocols.
How should reconstituted Sermorelin solutions be stored in the lab?
Reconstituted liquid solutions must be stored refrigerated at 2°C to 8°C. Solutions reconstituted with bacteriostatic water remain stable for up to 28 days under controlled refrigeration.
What target receptor does Sermorelin interact with?
Sermorelin acts as a direct selective agonist at the growth hormone-releasing hormone receptor (GHRHR), a Class B G-protein coupled receptor located primarily on anterior pituitary somatotrophs.
How does Sermorelin differ structurally from native GHRH?
Native endogenous GHRH consists of 44 amino acids. Sermorelin comprises the first 29 amino acids (GHRH 1-29), retaining the complete functional biological activity and receptor affinity of the full-length hormone.
Can Sermorelin 15mg be shipped at ambient temperature?
Yes. Lyophilized peptides are stable at ambient temperatures during typical transit times. Upon receipt at the laboratory facility, vials should immediately be placed in cold storage at -20°C for long-term preservation.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.